The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Virus-like particles: flexible platforms for vaccine development
Abstract
Virus-like particles (VLPs) consist of viral structural proteins that, when overexpressed, spontaneously self-assemble into particles that are antigenically indistinguishable from infectious virus or subviral particles. VLPs can be considered as dense, repetitive arrays of one or more protein subunits with properties that are highly advantageous for use as stand-alone vaccines or as vaccine platforms. This review discusses the development of VLP-based platform technologies for vaccines against pathogens, as well as nontraditional targets such as self-antigens involved in chronic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
Goodnow, C. C., Crosbie, J., Adelstein, S., Lavoie, T. B., Smith-Gill, S. J., Brink, R. A., Pritchard-Briscoe, H., Wotherspoon, J. S., Loblay, R. H., Raphael, K., et al. (1988) · Nature · doi:10.1038/334676a0 · Cited by 1,565
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
Nemazee, D. A., & Bürki, K. (1989) · Nature · doi:10.1038/337562a0 · Cited by 1,016
Receptor editing: an approach by autoreactive B cells to escape tolerance.
Gay, D., Saunders, T., Camper, S., & Weigert, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.999 · Cited by 920
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777
Receptor editing in self-reactive bone marrow B cells.
Tiegs, S. L., Russell, D. M., & Nemazee, D. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1009 · Cited by 766
A universal influenza A vaccine based on the extracellular domain of the M2 protein
Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M., & Fiers, W. (1999) · Nature Medicine · doi:10.1038/13484 · Cited by 752
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Hartley, S. B., Crosbie, J., Brink, R., Kantor, A. B., Basten, A., & Goodnow, C. C. (1991) · Nature · doi:10.1038/353765a0 · Cited by 695
Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
Fifis, T., Gamvrellis, A., Crimeen-Irwin, B., Pietersz, G. A., Li, J., Mottram, P. L., McKenzie, I. F. C., & Plebanski, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3148 · Cited by 664
Immunogenicity of engineered antibodies
Hwang, W. Y. K., & Foote, J. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.001 · Cited by 630
Harro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., & Rock, K. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4942 · Cited by 591
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Efficient Intracellular Assembly of Papillomaviral Vectors
Buck, C. B., Pastrana, D. V., Lowy, D. R., & Schiller, J. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.2.751-757.2004 · Cited by 489
NEUTRALIZING ANTIVIRAL B CELL RESPONSES
Bachmann, M. F., & Zinkernagel, R. M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.235 · Cited by 471
Mao, C., Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Wiley, D. J., Alvarez, F. B., Bautista, O. M., Jansen, K. U., & Barr, E. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000192397.41191.fb · Cited by 451
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Aide, P., Sigauque, B., Milman, J., Mandomando, I., Bassat, Q., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67669-6 · Cited by 412
A new foreign policy: MHC class I molecules monitor the outside world
Rock, K. L. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80605-0 · Cited by 403
Molecular determinants of immunogenicity: the immunon model of immune response.
Dintzis, H. M., Dintzis, R. Z., & Vogelstein, B. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.10.3671 · Cited by 383
Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein
Clarke, B. E., Newton, S. E., Carroll, A. R., Francis, M. J., Appleyard, G., Syred, A. D., Highfield, P. E., Rowlands, D. J., & Brown, F. (1987) · Nature · doi:10.1038/330381a0 · Cited by 333
Greenstone, H. L., Nieland, J. D., de Visser, K. E., Bruijn, M. L. H. D., Kirnbauer, R., Roden, R. B. S., Lowy, D. R., Kast, W. M., & Schiller, J. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1800 · Cited by 325
Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1777 · Cited by 286
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279
HBV Core Particles as a Carrier for B Cell/T Cell Epitopes
Pumpens, P., & Grens, E. (2001) · Intervirology · doi:10.1159/000050037 · Cited by 274
Papillomavirus-Like Particles Induce Acute Activation of Dendritic Cells
Lenz, P., Day, P. M., Pang, Y.-Y. S., Frye, S. A., Jensen, P. N., Lowy, D. R., & Schiller, J. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5346 · Cited by 252
Chackerian, B., Lowy, D. R., & Schiller, J. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11849 · Cited by 251
Self-citationNative display of complete foreign protein domains on the surface of hepatitis B virus capsids
Kratz, P. A., Böttcher, B., & Nassal, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1915 · Cited by 248
JEGERLEHNER, A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00266-9 · Cited by 226
Ambühl, P. M., Tissot, A. C., Fulurija, A., Maurer, P., Nussberger, J., Sabat, R., Nief, V., Schellekens, C., Sladko, K., Roubicek, K., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32800ff5d6 · Cited by 219
Hybrid Virus−Polymer Materials. 1. Synthesis and Properties of PEG-Decorated Cowpea Mosaic Virus
Raja, K. S., Wang, Q., Gonzalez, M. J., Manchester, M., Johnson, J. E., & Finn, M. G. (2003) · Biomacromolecules · doi:10.1021/bm025740+ · Cited by 205
Role of B cells in antigen presentation of the hepatitis B core
Milich, D. R., Chen, M., Schödel, F., Peterson, D. L., Jones, J. E., & Hughes, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14648 · Cited by 201
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
Kündig, T. M., Senti, G., Schnetzler, G., Wolf, C., Prinz Vavricka, B. M., Fulurija, A., Hennecke, F., Sladko, K., Jennings, G. T., & Bachmann, M. F. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.01.040 · Cited by 199
Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis
Röhn, T. A., Jennings, G. T., Hernandez, M., Grest, P., Beck, M., Zou, Y., Kopf, M., & Bachmann, M. F. (2006) · European Journal of Immunology · doi:10.1002/eji.200636658 · Cited by 195
Natural Supramolecular Building Blocks
Wang, Q., Lin, T., Johnson, J. E., & Finn, M. G. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00166-7 · Cited by 192
Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles
Chackerian, B., Lenz, P., Lowy, D. R., & Schiller, J. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6120 · Cited by 181
Self-citationFehr, T., Skrastina, D., Pumpens, P., & Zinkernagel, R. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9477 · Cited by 172
Sedlik, C., Saron, M.-F., Sarraseca, J., Casal, I., & Leclerc, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7503 · Cited by 168
Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis
Sonderegger, I., Röhn, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F., & Kopf, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200636484 · Cited by 167
HPV6b virus like particles are potent immunogens without adjuvant in man
Zhang, L. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00351-5 · Cited by 163
Bachmann, M. F., Lutz, M. B., Layton, G. T., Harris, S. J., Fehr, T. H., Rescigno, M., & Ricciardi‐Castagnoli, P. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261109 · Cited by 161
Nardelli-Haefliger, D., Roden, R. B., Benyacoub, J., Sahli, R., Kraehenbuhl, J. P., Schiller, J. T., Lachat, P., Potts, A., & De Grandi, P. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3328-3336.1997 · Cited by 160
Rudolf, M. P., Fausch, S. C., Silva, D. M. D., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5917 · Cited by 155
Mastico, R. A., Talbot, S. J., & Stockley, P. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-4-541 · Cited by 142
Hofmann, K. J., Cook, J. C., Joyce, J. G., et al. (1995) · Virology · doi:10.1006/viro.1995.1283 · Cited by 134
Morón, G., Rueda, P., Casal, J. I., & Leclerc, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011930 · Cited by 129
Papillomavirus Virus-like Particles Can Deliver Defined CTL Epitopes to the MHC Class I Pathway
Peng, S., Frazer, I. H., Fernando, G. J. P., & Zhou, J. (1998) · Virology · doi:10.1006/viro.1997.8912 · Cited by 125
Chackerian, B., Rangel, M., Hunter, Z. N., & Peabody, D. S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.059 · Cited by 121
Self-citationInduction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles
Chackerian, B., Lowy, D. R., & Schiller, J. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2373 · Cited by 117
Self-citationTherapeutic vaccination for chronic diseases: a new class of drugs in sight
Bachmann, M. F., & Dyer, M. R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1284 · Cited by 115
Ebola and Marburg virus-like particles activate human myeloid dendritic cells
Bosio, C. M., Moore, B. D., Warfield, K. L., Ruthel, G. T., Mohamadzadeh, M., Aman, M. J., & Bavari, S. (2004) · Virology · doi:10.1016/j.virol.2004.05.025 · Cited by 111
New tools for antigen delivery to the MHC class I pathway
Morón, G., Dadaglio, G., & Leclerc, C. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.008 · Cited by 109
Oliveira, G. A., Wetzel, K., Calvo‐Calle, J. M., Nussenzweig, R. S., Schmidt, A., Birkett, A. J., Dubovsky, F., Tierney, E. L., Gleiter, C. H., Boehmer, G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3587-3597.2005 · Cited by 106
Nardin, E. H., Oliveira, G. A., Calvo‐Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P. P., Corado, M. L., Thornton, G. B., & Schmidt, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6519-6527.2004 · Cited by 99
Antibodies as therapeutic agents: vive la renaissance!
Stockwin, L., & Holmes, S. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.7.1133 · Cited by 92
McCormick, A. A., Corbo, T. A., Wykoff-Clary, S., Nguyen, L. V.-H., Smith, M. L., Palmer, K. E., & Pogue, G. P. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.003 · Cited by 85
Skountzou, I., Quan, F., Gangadhara, S., Ye, L., Vzorov, A. N., Selvaraj, P., Jacob, J., Compans, R. W., & Kang, S. (2006) · Journal of Virology · doi:10.1128/jvi.01692-06 · Cited by 83
Tsunetsugu‐Yokota, Y., Morikawa, Y., Isogai, M., Kawana‐Tachikawa, A., Odawara, T., Nakamura, T., Grassi, M. F. R., Autran, B., & Iwamoto, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10250-10259.2003 · Cited by 82
Silva, D. M. D., Pastrana, D. V., Schiller, J. T., & Kast, W. M. (2001) · Virology · doi:10.1006/viro.2001.1179 · Cited by 73
Efficient homologous prime‐boost strategies for T cell vaccination based on virus‐like particles
Schwarz, K., Meijerink, E., Speiser, D. E., Tissot, A. C., Cielēns, I., Renhof, R., Dišlers, A., Pumpens, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200425755 · Cited by 69
A Viral Platform for Chemical Modification and Multivalent Display
Peabody, D. S. (2003) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-1-5 · Cited by 68
Kang, S., Yao, Q. C., Guo, L., & Compans, R. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9823-9830.2003 · Cited by 61
Polyvalent Antigens Stabilize B Cell Antigen Receptor Surface Signaling Microdomains
Thyagarajan, R., Arunkumar, N., & Song, W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6099 · Cited by 60
Silva, D. M. D., Schiller, J. T., & Kast, W. M. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00237-8 · Cited by 59
Spohn, G., Schwarz, K., Maurer, P., Illges, H., Rajasekaran, N., Choi, Y., Jennings, G. T., & Bachmann, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6211 · Cited by 58
Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops
Slupetzky, K., Shafti‐Keramat, S., Lenz, P., et al. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-11-2799 · Cited by 58
Zamora, E. D., Handisurya, A., Shafti‐Keramat, S., Borchelt, D., Rudow, G. L., Conant, K. E., Cox, C., Troncoso, J. C., & Kirnbauer, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2662 · Cited by 56
Nieland, J. D., Silva, D. M. D., Velders, M. P., de Visser, K. E., Schiller, J. T., M�ller, M., & Kast, W. M. (1999) · Journal of Cellular Biochemistry · Cited by 53
Li, Q., Cao, C., Chackerian, B., Schiller, J. T., Gordon, M. N., Ugen, K. E., & Morgan, D. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-21 · Cited by 50
Self-citationA second vaccine revolution for the new epidemics of the 21st century
Dyer, M. R., Renner, W. A., & Bachmann, M. F. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.09.006 · Cited by 29
Gathuru, J., Koide, F., Ragupathi, G., Adams, J. L., Kerns, R. T., Coleman, T. P., & Livingston, P. O. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.05.007 · Cited by 20
Cited by
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Kushnir, N., Streatfield, S. J., & Yusibov, V. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.083 · Cited by 587
Akahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · bchm · doi:10.1515/bc.2008.064 · Cited by 369
Metadata
- Authors
- Chackerian, B.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2007-06
- Volume
- 6
- Issue
- 3
- Pages
- 381-390
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2007622060
- Cited by
- 321
- References
- 78
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.